21:26 , Nov 21, 2018 |  BC Extra  |  Company News

Management tracks: BerGenBio, Alzamend

BerGenBio ASA (OSE:BGBIO) said Clinical Development Officer Murray Yule will step down on Nov. 30. The cancer company hired former Amgen Inc. (NASDAQ:AMGN) and AstraZeneca plc (LSE:AZN; NYSE:AZN) leader Alan Barge as interim CMO. Barge...
08:00 , Nov 24, 2014 |  BC Week In Review  |  Financial News

BioNano Genomics completes venture financing

BioNano Genomics Inc. , San Diego, Calif.   Business: Diagnostic, Genomics, Supply/Service   Date completed: 2014-11-20   Type: Venture financing   Raised: $53 million   Investors: Legend Capital; Novartis Venture Funds; Federated Kaufmann Fund; Monashee...
02:56 , Nov 21, 2014 |  BC Extra  |  Financial News

BioNano raises $53M in series C

BioNano Genomics Inc. (San Diego, Calif.) raised $53 million in an untranched series C round led by new investors Legend Capital and Novartis Venture Fund. Other new investors included Federated Kaufmann Fund and Monashee Investment...
08:00 , Dec 9, 2013 |  BC Week In Review  |  Company News

Zogenix, Battelle sales and marketing update

Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif.   Battelle , Columbus, Ohio   Business: Drug delivery   Zogenix and Battelle extended to Nov. 26, 2018, a 2012 deal to co-market Zogenix's DosePro needle-free drug delivery technology....
07:00 , Oct 7, 2013 |  BC Week In Review  |  Financial News

BioNano Genomics completes venture financing

BioNano Genomics Inc. , San Diego, Calif.   Business: Diagnostic, Genomics, Supply/Service   Date completed: 10/2/13   Type: Venture financing   Raised: $10 million   Investors: Battelle Ventures; Domain Associates; Gund Investment  ...
07:00 , Apr 1, 2013 |  BC Week In Review  |  Company News

Zogenix, Battelle deal

Zogenix and CRO, laboratory management and technology commercialization company Battelle extended to March 29, 2014, a 2012 deal to co-market Zogenix's DosePro needle-free drug delivery technology. DosePro uses compressed gas to deliver liquid formulations subcutaneously....
02:12 , Feb 14, 2013 |  BC Extra  |  Politics & Policy

Obama targets drug companies, supports NIH

In his Battelle Memorial Institute on the economic impact of the project....
08:00 , Jan 24, 2013 |  BC Innovations  |  Tools & Techniques

Sarepta's hemorrhagic mouse

A team at Sarepta Therapeutics Inc. has developed a mouse model of arenavirus infection that recapitulates key symptoms of the disease including hemorrhagic fever and multiorgan failure. 1 The researchers now want to use the...
07:00 , Jul 16, 2012 |  BC Week In Review  |  Financial News

BioNano Genomics completes venture financing

BioNano Genomics Inc. , San Diego, Calif.   Business: Diagnostic, Genomics, Supply/Service   Date completed: 6/29/12   Type: Venture financing   Raised: $10 million   Investors: Battelle Ventures; Domain Associates; Gund Investment; Innovation Valley Partners...
08:00 , Jan 30, 2012 |  BC Week In Review  |  Company News

Zogenix, Battelle deal

Zogenix signed a letter of intent with CRO, laboratory management and technology commercialization company Battelle to co-market Zogenix's DosePro needle-free drug delivery technology. DosePro uses compressed gas to deliver liquid formulations subcutaneously. Upon out-licensing of...